Vetia

Vetia is a specialized pharmaceutical company headquartered in Buenos Aires, Argentina, and operates as a key commercial subsidiary of the Insud Pharma group. The company is dedicated to the distribution and marketing of high-complexity therapies, with a primary focus on oncology, hematology, and rheumatology. Vetia is instrumental in expanding access to advanced treatments in Latin America, particularly through its portfolio of biosimilar monoclonal antibodies produced by its affiliate, mAbxience. By providing specialized medications for chronic and rare diseases, Vetia supports healthcare providers and patients with high-quality therapeutic alternatives. The company maintains a strong presence in the Argentine market, leveraging the global research and manufacturing capabilities of its parent organization.